XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Condensed Consolidated Statements of Operations (Unaudited)        
Revenues $ 1,757,774 $ 363,052 $ 2,481,602 $ 568,164
Cost of revenues (1,176,032) (103,638) (1,536,074) (174,395)
Gross profit 581,742 259,414 945,528 393,769
Operating expenses:        
Research and development expenses 1,834,786 646,798 5,047,096 646,798
Selling, general and administrative expenses 6,569,227 795,958 7,748,060 2,178,969
Total operating expenses 8,404,013 1,442,756 12,795,156 2,825,767
Operating loss (7,822,271) (1,183,342) (11,849,628) (2,431,998)
Non-operating income and expenses        
Interest income and expenses, net (9,821) 23,517 (45,304) (9,361)
Other income and expenses, net 10,336 (285) 19,250 (2,532)
Total non-operating income and expenses, net 515 23,232 (26,054) (11,893)
Net loss $ (7,821,756) $ (1,160,110) $ (11,875,682) $ (2,443,891)
Net loss per common shares-basic and diluted $ (0.51) $ (0.12) $ (1.03) $ (0.48)
Weighted average common shares outstanding- basic and diluted 15,301,396 9,494,468 11,538,013 5,061,160